Background Advances in diagnostic and therapeutic strategies in oncology have
significantly increased the chance of survival of cancer patients, even those with metastatic …

Answer questions and earn CME/CNE Over the past few decades, a body of research has
emerged confirming what many adult patients with noncentral nervous system cancer have …

One in three people will be diagnosed with cancer during their lifetime. The community of
cancer patients is growing, and several common cancers are becoming increasingly …

Survivors of early-stage breast cancer may report treatment-related side effects that persist
for several years after the end of primary treatment. Among these, fatigue and cognitive …

Cancer and its treatments are associated with increased risk for cancer-related cognitive
impairment (CRCI). Methods and measures used to study and assess self-reported CRCI (sr …

A wide range of cognitive deficits, including memory loss associated with hippocampal
dysfunction, have been widely reported in cancer survivors who received chemotherapy …

Importance Chemotherapy exposure is a known risk factor for cancer-related cognitive
impairments. Anthracycline-based regimens are commonly used chemotherapies that have …

This systematic review explored the neurobiological mechanisms underlying the clinical
time course of cancer-related cognitive impairment (CRCI) in breast cancer patients through …

Cancer-and treatment-related cognitive changes have been a focus of increasing research
since the early 1980s, with meta-analyses demonstrating poorer performance in cancer …

We aimed to determine if resting state functional magnetic resonance imaging (fMRI)
acquired at pre-treatment baseline could accurately predict breast cancer-related cognitive …